Organon & Co.
NYSE:OGN · New York Stock Exchange
+$0.01 today
Vol 2.14M · Avg 8.57M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+38.17%
Period High
$13.46
Period Low
$5.69
Latest
$13.43
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Guardian Pharmacy Services, Inc.
NYSE:GRDN
$2.74B
Avadel Pharmaceuticals plc
AVDL
$2.12B
Aurinia Pharmaceuticals Inc.
NASDAQ:AUPH
$2.10B
Select Medical Holdings Corporation
NYSE:SEM
$2.05B
Harmony Biosciences Holdings, Inc.
NASDAQ:HRMY
$1.94B
Nuvation Bio Inc.
NYSE:NUVB
$1.91B
Pediatrix Medical Group, Inc.
NYSE:MD
$1.90B
Phibro Animal Health Corporation
NASDAQ:PAHC
$1.27B
Alvotech
NASDAQ:ALVO
$1.22B
Tilray Brands, Inc.
NASDAQ:TLRY
$560.02M
What is the latest OGN filing?
The latest filing shown is DEFM14A dated Jun 17, 2026.
How many recent filings does OGN have?
Intrinsic Alpha currently shows 20 recent filings for OGN.
Explore More
Continue the stock analysis
Jump to another research area for this company.